Secreted matrix metallopeptidase-2 (MMP-2) and urokinase plasminogen activator surface receptor (uPAR) have been demonstrated to activate focal adhesion kinase (FAK), which acts as an executioner of BCL-w-dependent invasive phenotype of gastric cancer cells144. The gene discussed is BCL2L2; the disease is gastric cancer.